𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Unusual antiproliferative effects of transforming growth factors-β1 andβ2 against primary cells from human tumors

✍ Scribed by Anna Marie Daniels; John M. McPherson; John R. Daniels; Karl A. Piez

Publisher
Springer
Year
1989
Tongue
English
Weight
401 KB
Volume
1
Category
Article
ISSN
0921-299X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multidrug transport in human glioblastom
Multidrug transport in human glioblastoma cells is inhibited by transforming growth factors type β1, β2, and β1.2
✍ Ph.D. H. J. Schluesener 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB 👁 1 views

The transforming growth factors type PI, p2, and p,.2 suppress multidrug transport in human pat-1 glioblastoma cells and even in cells that strongly overexpress mdr genes and are resistant to inhibition of multidrug transport by chemosensitizers. Thus, inhibition of multidrug transport by cytokines

Transforming growth factors type β1 and
Transforming growth factors type β1 and β2 are equipotent growth inhibitors of human breast cancer cell lines
✍ Gerhard Zugmaier; Bruce W. Ennis; Bernd Deschauer; Deborah Katz; Cornelius Knabb 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 735 KB

At least one member of the TGF-P family, TGF-p1, has been previously shown to inhibit the anchorage-independent growth of some human breast cancer cell lines (Knabbe et al., 1487; Arteaga et al., 1988). Members of the TGF-P family might, [herefore, provide new strategies for breast cancer therapy. W

Transforming growth factor β1 (TGF-β1) i
Transforming growth factor β1 (TGF-β1) inhibits growth of a human ovarian carcinoma cell line (OVCCR1) and is expressed in human ovarian tumors
✍ S. Jozan; M. Guerrin; P. Mazars; M. Dutaur; B. Monsarrat; F. Cheutin; R. Bugat; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 957 KB

## Abstract The effects of EGF and TGF‐β1 on the proliferation of 2 ovarian carcinoma cell lines (IGROV1 and OVCCR1) were evaluated. The cell lines were adapted to grow in a restricted serum (0.5%) medium. EGF was required for proliferation of both ovarian cell lines. Low doses of TGF‐β1 inhibited

Stimulation of interleukin-11 production
Stimulation of interleukin-11 production from osteoblast-like cells by transforming growth factor-β and tumor cell factors
✍ Yoshihiro Morinaga; Naoya Fujita; Kazuo Ohishi; Takashi Tsuruo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 158 KB 👁 2 views

Bone is one of the most common sites of metastasis in melanoma and breast cancer cells. Human melanoma (A375M) and human breast cancer (MDA-MB-231) cells form osteolytic bone metastasis in vivo when these tumor cells are injected into the left ventricles of BALB/c nude mice. These tumor cells promot

Enhanced tumorigenesis and reduced trans
Enhanced tumorigenesis and reduced transforming growth factor-β type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-β1
✍ Yang Kang; Jennifer M. Mariano; Jerry Angdisen; Terry W. Moody; Bhalchandra A. D 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB 👁 1 views

To elucidate the role of transforming growth factor-beta1 (TGF-beta1) and the TGF-beta type II receptor (TGF-beta RII) as tumor-suppressor genes in lung carcinogenesis, we mated C57BL/6 mice heterozygous (HT) for deletion of the TGF-beta1 gene with A/J mice to produce AJBL6 TGF-beta1 HT progeny and